195 related articles for article (PubMed ID: 36187116)
21. The effect of circadian rhythm on prolactin/PRLR-mediated intracellular signaling profiles in vivo and in vitro.
Yuzhen C; Zheng F
Tissue Cell; 2021 Dec; 73():101570. PubMed ID: 34343759
[TBL] [Abstract][Full Text] [Related]
22. The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate.
Araya-Secchi R; Bugge K; Seiffert P; Petry A; Haxholm GW; Lindorff-Larsen K; Pedersen SF; Arleth L; Kragelund BB
Elife; 2023 May; 12():. PubMed ID: 37232489
[TBL] [Abstract][Full Text] [Related]
23. Prolactin Regulates Ovine Ovarian Granulosa Cell Apoptosis by Affecting the Expression of
Yang R; Duan C; Zhang S; Liu Y; Zhang Y
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373417
[TBL] [Abstract][Full Text] [Related]
24. High Prolactin Concentration Induces Ovarian Granulosa Cell Oxidative Stress, Leading to Apoptosis Mediated by
Yang R; Duan C; Zhang S; Guo Y; Shan X; Chen M; Yue S; Zhang Y; Liu Y
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833858
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.
Alkharusi A; Yu S; Landázuri N; Zadjali F; Davodi B; Nyström T; Gräslund T; Rahbar A; Norstedt G
Oncotarget; 2016 Nov; 7(48):79572-79583. PubMed ID: 27788487
[TBL] [Abstract][Full Text] [Related]
26. Recent findings on hyperprolactinemia and its pathological implications: a literature review.
Ghoreshi ZA; Akbari H; Sharif-Zak M; Arefinia N; Abbasi-Jorjandi M; Asadikaram G
J Investig Med; 2022 Oct; 70(7):1443-1451. PubMed ID: 35768141
[TBL] [Abstract][Full Text] [Related]
27. PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.
Yang T; Chi Y; Wang X; Xu C; Chen X; Liu Y; Huang S; Zhu X; Zhang H; Zhuo H; Wu D
Cell Death Dis; 2024 Feb; 15(2):128. PubMed ID: 38341429
[TBL] [Abstract][Full Text] [Related]
28. The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.
Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
[TBL] [Abstract][Full Text] [Related]
29. The Diversity of Gut Microbiota at Weaning Is Altered in Prolactin Receptor-Null Mice.
Luzardo-Ocampo I; Ocampo-Ruiz AL; Dena-Beltrán JL; Martínez de la Escalera G; Clapp C; Macotela Y
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571383
[TBL] [Abstract][Full Text] [Related]
30. A Novel Mechanism of hPRL-G129R, a Prolactin Antagonist, Inhibits Human Breast Cancer Cell Proliferation and Migration.
Li R; Yang Y; Lan H; Wang Y; Ge Z; Liu X; Zhou Y; Zhang W; Xian L; Yuan H
Endocrinology; 2023 Nov; 164(12):. PubMed ID: 37934803
[TBL] [Abstract][Full Text] [Related]
31. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms.
Taghi Khani A; Kumar A; Sanchez Ortiz A; Radecki KC; Aramburo S; Lee SJ; Hu Z; Damirchi B; Lorenson MY; Wu X; Gu Z; Stohl W; Sanz I; Meffre E; Müschen M; Forman SJ; Koff JL; Walker AM; Swaminathan S
Commun Biol; 2023 Mar; 6(1):295. PubMed ID: 36941341
[TBL] [Abstract][Full Text] [Related]
32. Preparation of Superactive Prolactin Receptor Antagonists.
Solomon G; Oclon E; Hayouka Z; Gertler A
Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36351045
[TBL] [Abstract][Full Text] [Related]
33. The Choroid Plexus Is an Alternative Source of Prolactin to the Rat Brain.
Costa-Brito AR; Quintela T; Gonçalves I; Duarte AC; Costa AR; Arosa FA; Cavaco JE; Lemos MC; Santos CRA
Mol Neurobiol; 2021 Apr; 58(4):1846-1858. PubMed ID: 33409838
[TBL] [Abstract][Full Text] [Related]
34. Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer.
Shehadeh-Tout F; Milioli HH; Roslan S; Jansson PJ; Dharmasivam M; Graham D; Anderson R; Wijesinghe T; Azad MG; Richardson DR; Kovacevic Z
Pharmacol Res; 2023 Jul; 193():106806. PubMed ID: 37244387
[TBL] [Abstract][Full Text] [Related]
35. [Prolactin and its receptor: From animal models to pituitary pathophysiology].
Begon E; Bernard V
Biol Aujourdhui; 2022; 216(3-4):105-110. PubMed ID: 36744975
[TBL] [Abstract][Full Text] [Related]
36. Prolactin Regulates Testicular Gene Expression and Cell Cycle Processes Predominantly via JAK2/STAT5 Pathway in the Male Rat.
Raut S; Khambata K; Goffin V; Balasinor N
Endocrinology; 2023 Jun; 164(7):. PubMed ID: 37232379
[TBL] [Abstract][Full Text] [Related]
37. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers.
Hathaway CA; Rice MS; Collins LC; Chen D; Frank DA; Walker S; Clevenger CV; Tamimi RM; Tworoger SS; Hankinson SE
Breast Cancer Res; 2023 Mar; 25(1):24. PubMed ID: 36882838
[TBL] [Abstract][Full Text] [Related]
38. Prolactin and the evolution of male pregnancy.
Wilson AB; Whittington CM; Meyer A; Scobell SK; Gauthier ME
Gen Comp Endocrinol; 2023 Apr; 334():114210. PubMed ID: 36646326
[TBL] [Abstract][Full Text] [Related]
39. Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia.
Cuesta-Casanovas L; Delgado-Martínez J; Cornet-Masana JM; Carbó JM; Banús-Mulet A; Guijarro F; Esteve J; Risueño RM
Cancer Cell Int; 2023 May; 23(1):97. PubMed ID: 37208719
[TBL] [Abstract][Full Text] [Related]
40. Codonopsis lanceolata polysaccharide ameliorates high-fat diet induced-postpartum hypogalactia via stimulating prolactin receptor-mediated Jak2/Stat5 signaling.
Chen S; Long M; Li XY; Li QM; Pan LH; Luo JP; Zha XQ
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129114. PubMed ID: 38181915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
